Presented by John Fox at ASM Microbe in Houston, Texas 2024 Bacterial HAIs are a substantial source of global morbidity and mortality, resulting in increased length of hospital stay and high healthcare costs. At Genpax, we're often asked what the benefit of adopting a WGS led intervention strategy could have on hospitals systems, so we developed at thorough model to work it out. Our findings will be presented at the forthcoming ASM Microbe 23 meeting in Houston in June. If y

Presented by James Littlefair at ECCMID in Copenhagen, 2023 Download high-resolution pdf below: At ECCMID 2023 in Copenhagen, we displayed some of the findings regarding our near-zero error capabilities generated from our platform which will be launched commercially this summer. Calling Zero: A new foundation for diagnostic bacterial genomics James C. Littlefair, Benedict J. Uttley, Dan G. Frampton, Gareth M. Linsmith, John F. Peden, & Nigel J. Saunders Reference ECCMID

The same features of the Genpax analysis that mean that all strains of a species can be compared in one location with a common analysis resource (as opposed to others, such as those that must use multiple reference genomes or where resolution reduces with increasing numbers and diversity of strains), and its open scalability means it will generate equally comparable and integratable findings from information generated and submitted from different laboratories. This is enabled